Blockchain Registration Transaction Record

HeartBeam to Reveal 2025 Results & ECG Patch Progress in March 2026 Call

HeartBeam (NASDAQ: BEAT) announces a conference call on March 12, 2026, to discuss 2025 financial results and updates on its FDA-cleared 12-lead ECG patch technology.

This news matters because HeartBeam's advancements in portable, 3D ECG technology represent a transformative shift in cardiac care, potentially saving lives through early detection and remote monitoring. With FDA clearance for its 12-lead ECG synthesis software, the company is addressing critical gaps in healthcare accessibility, allowing patients to receive timely diagnoses outside traditional medical settings. For investors, it signals growth in a high-impact sector, while for the public, it offers hope for reduced heart disease burdens through innovative, patient-centric solutions that could lower healthcare costs and improve outcomes globally.